These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16652385

  • 1. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
    Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, Laird DW, Alaoui-Jamali MA.
    Prostate; 2006 Aug 01; 66(11):1151-61. PubMed ID: 16652385
    [Abstract] [Full Text] [Related]

  • 2. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H, Wu X.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):860-7. PubMed ID: 15474507
    [Abstract] [Full Text] [Related]

  • 3. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus.
    Ogawa T, Hayashi T, Tokunou M, Nakachi K, Trosko JE, Chang CC, Yorioka N.
    Cancer Res; 2005 Nov 01; 65(21):9771-8. PubMed ID: 16266998
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM, Soeth E, Smith CL.
    Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222
    [Abstract] [Full Text] [Related]

  • 5. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 6. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 7. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 15; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J, Colburn NH.
    Mol Cancer Res; 2005 Feb 15; 3(2):100-9. PubMed ID: 15755876
    [Abstract] [Full Text] [Related]

  • 9. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Björkholm M, Henriksson M, Gruber A, Xu D.
    Exp Cell Res; 2002 Mar 10; 274(1):25-34. PubMed ID: 11855854
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase 3 represses HTLV-1 tax transcription.
    Villanueva R, Iglesias AH, Camelo S, Sanin LC, Gray SG, Dangond F.
    Oncol Rep; 2006 Sep 01; 16(3):581-5. PubMed ID: 16865259
    [Abstract] [Full Text] [Related]

  • 12. Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth.
    Hattori Y, Fukushima M, Maitani Y.
    Int J Oncol; 2007 Jun 01; 30(6):1427-39. PubMed ID: 17487363
    [Abstract] [Full Text] [Related]

  • 13. Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells.
    Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, Hwang JW, Aruoma OI, Lee YS, Kang KS.
    Cancer Lett; 2006 Sep 28; 241(2):301-8. PubMed ID: 16337085
    [Abstract] [Full Text] [Related]

  • 14. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
    Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM, Feng J, Liu D, Chiao JW.
    Int J Oncol; 2008 Aug 28; 33(2):375-80. PubMed ID: 18636159
    [Abstract] [Full Text] [Related]

  • 15. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U, Renkawitz R, Baniahmad A.
    Anticancer Res; 2000 Aug 28; 20(2A):1017-22. PubMed ID: 10810390
    [Abstract] [Full Text] [Related]

  • 16. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 17. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S, Lu J, Zhang Y, Cheng C, Li L, Han L, Huang B.
    Immunol Lett; 2007 Feb 15; 108(2):143-50. PubMed ID: 17270283
    [Abstract] [Full Text] [Related]

  • 18. IFI16 in human prostate cancer.
    Alimirah F, Chen J, Davis FJ, Choubey D.
    Mol Cancer Res; 2007 Mar 15; 5(3):251-9. PubMed ID: 17339605
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K, Saatcioglu F.
    Prostate; 2005 Feb 15; 62(3):299-306. PubMed ID: 15389787
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of HDAC inhibitor-induced thrombocytopenia.
    Matsuoka H, Unami A, Fujimura T, Noto T, Takata Y, Yoshizawa K, Mori H, Aramori I, Mutoh S.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):88-96. PubMed ID: 17628529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.